Compare stocks

ChemoMetec A/S is engaged in the development, manufacturing, and marketing of analytical instruments used for counting and analyzing cells in a variety of applications across biotechnology, pharmaceuticals, and academic research sectors. The company’s main product lines include automated cell counters and analyzers, such as the NucleoCounter series. Founded in 1997, ChemoMetec is headquartered in Allerod, Denmark. The company is noted for its focus on innovation in cell counting technology, providing precise and user-friendly solutions that facilitate laboratory workflows and enhance data accuracy. Its strategic position in the analytical instruments industry is strengthened by its commitment to quality and reliability in measurement instrumentation.

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.